A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinoma.
Qili ShiYizhe LiuMingxing LuQun-Ying LeiZhiao ChenLu WangXianghuo HePublished in: Comput. Biol. Medicine (2022)
Keyphrases
- prediction accuracy
- therapy planning
- metabolic networks
- prediction model
- fault diagnosis
- survival analysis
- prediction algorithm
- prediction error
- precision and recall
- breast cancer
- optimal strategy
- fold cross validation
- patient specific
- predictive modeling
- digital signature
- regulatory networks
- escherichia coli
- outcome prediction